CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)

32.48 0.00 (0.00%) USD  |  NASDAQ  |  Mar 25, 16:00
More

CymaBay Therapeutics PE Ratio

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2014. Upgrade now.
Date Value
March 25, 2014 21.58
March 20, 2014 20.23
March 18, 2014 21.55
March 17, 2014 20.27
March 07, 2014 21.58
March 06, 2014 21.58
Date Value
March 05, 2014 21.58
February 27, 2014 24.27
February 26, 2014 24.27
February 13, 2014 24.27
February 03, 2014 24.27
January 27, 2014 24.27

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

Gilead Sciences Inc 181.50
Assure Holdings Corp --
Societal CDMO Inc (DELISTED) --
AN2 Therapeutics Inc --
Madrigal Pharmaceuticals Inc --

PE Ratio Related Metrics

Price to Book Value 12.76
Price 32.48
Earnings Yield -3.05%